More Business Wire
View Older Stories View Newer Stories-
Merck to Hold Third-Quarter 2026 Sales and Earnings Conference Call Oct. 29
-
Ares Raises $4.2 Billion for Inaugural Global Structured Solutions Strategy
-
AIG Appoints Turab Hussain Chief Risk Officer
-
Avery Dennison to Webcast Third Quarter 2026 Earnings Conference Call
-
Innovative Industrial Properties Announces Mezzanine Loan Commitment of $245 Million for Alewife Park
-
Accenture Reports Fourth-Quarter and Full-Year Fiscal 2026 Results
-
NICE issues final draft guidance recommending ▼ Tryngolza® (olezarsen) as an option to treat genetically confirmed familial chylomicronaemia syndrome (FCS) in adults in England and Wales
-
Integrated Dermatology Promotes Nicholas Anguish to Chief Executive Officer
-
BlackRock Future Builders™ Expands Nationwide to Help Thousands of American Workers Access Skilled Trades Careers
-
Trane Technologies Introduces Residential Cold Climate Heat Pumps Built for Extreme Winter Performance
-
Entomo Brands Selects Troy Lindbeck as Chief Executive Officer to Drive Continued Growth and Expansion
-
Qnity Schedules Third Quarter 2026 Earnings Release and Conference Call
-
Pursuit Submits Proposal to Develop Sightseeing Tram Near Glacier National Park
-
Nextdoor to Transfer Stock Exchange Listing to Nasdaq Capital Market
-
Anaergia Signs Definitive Agreement to Divest Non-Core Assets, Charlotte and Rhode Island Bioenergy Facilities
-
BrightView Goes Pink for Third Annual Breast Cancer Awareness Campaign
-
Mayville Engineering Company Announces Strategic Footprint Expansion in the Southeastern U.S.
-
Forbright, Inc. Schedules Release of Third Quarter 2026 Financial Results
-
Powerful Medical and corpuls Partner to Bring Queen of Hearts AI-Powered Heart Attack Detection to Prehospital Care
-
Magnolia Oil & Gas Provides Interim Financial and Operations Update After Closing the Acquisition of WildFire Energy
-
Monroe Capital Prices $398.9 Million Private Credit CLO
-
Everlywell Brings Clairity’s FDA-Authorized AI Breast Cancer Risk Assessment to Women Nationwide
-
LEO Pharma presents new data on delgocitinib cream at EADV 2026 highlighting real-world outcomes in adults and new adolescent data in Chronic Hand Eczema (CHE)
-
Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
-
Lumentum Announces Speaker Lineup at 2026 OCP Global Summit
-
Defense Health Agency Selects Hypori to Secure Clinical Dictation on Clinicians' Personal Phones
-
FreeCast Provides Additional Detail on Previously Announced Fiscal 2026 Results
-
LEO Pharma presents new tralokinumab data at EADV 2026 highlighting real-world outcomes and quality of life in adults and adolescents with atopic dermatitis (AD) involving high-burden areas
-
Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates
-
FPT and ZEBOX Partner to Advance AI and Sustainable Innovation in Logistics
-
Study: 52% of Tariff-Impacted Small Businesses Are Performing Worse, While Most Haven’t Felt the Buy Canadian Boost
-
Telekom Srbija (Group) Is Building City-Scale Digital Infrastructure for EXPO 2027
-
Panther Doubles Its Client Base and Launches Intelligence Model to Back the Agencies Staffing the UK's Critical Industries
-
AI Delivers Value, but Only 13% of Organizations Scale It as Planned
-
AM Best to Attend 2026 Baden-Baden Reinsurance Meeting
-
ROYC Group Launches ROYC Operating System as a Standalone Enterprise Software Platform
-
The Palm Beach Hedge Fund Association Announces a Strategic Collaboration with the AnchoraA Fund (A Voyage Capital & HotelShift Venture)
-
SkyDrive: Converting Osaka City’s Rooftop Emergency Landing Sites into eVTOL Vertiports
-
Ares Provides $2 Billion Debt Facility to Phoenix Tower International
-
Wolters Kluwer expands LEX and Libra integration in Poland by making Libra AI capabilities directly available in LEX
-
Eaton Strengthens European Manufacturing With Expanded Production Facility in Austria
-
Aegir Insights Launches Next-Generation Energy Intelligence Platform
-
Dunbar Pharma Supplies API for UK’s First Plant-Derived Dronabinol Oral Spray
-
EADV 2026: Long-Term Disease Control for up to Five Years in Patients With Moderate-to-Severe Atopic Dermatitis Treated With Lebrikizumab
-
Advanced MRI Imaging Reveals Changes in Muscle Composition and Fat Infiltration During Obesity Treatment
-
Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study
-
Arkema Invests €10 Million in Its Global Battery R&D Center of Excellence in the Lyon Region
-
Ares Strengthens Commitment to Plenitude Through €1 Billion Capital Contribution
-
ADS-TEC Energy Reports First Half 2026 Results; Advances Gigawatt-Scale SKM Storage Project and Strengthens its Position to Scale Own & Operate Model
-
Orifarm Unveils 2031 Strategy to Accelerate Growth Across Europe, With Significant Expansion in Generics
